These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 15449490)

  • 1. Fracture protection in osteoporosis with risedronate.
    Boonen S; Vanderschueren D
    Hosp Med; 2004 Sep; 65(9):535-40. PubMed ID: 15449490
    [No Abstract]   [Full Text] [Related]  

  • 2. Risedronate: a new oral bisphosphonate.
    Roll KT
    Clin Ther; 2002 May; 24(5):835-6. PubMed ID: 12075950
    [No Abstract]   [Full Text] [Related]  

  • 3. Review of the safety and efficacy of risedronate for the treatment of male osteoporosis.
    Bobba R; Adachi JD
    Clin Interv Aging; 2007; 2(3):275-82. PubMed ID: 18044178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bisphosphonate therapy.
    Licata AA
    Am J Med Sci; 1997 Jan; 313(1):17-22. PubMed ID: 9001162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteoporosis in older people: a tale of two studies (and three treatments).
    Troen BR
    J Am Geriatr Soc; 2006 May; 54(5):853-5. PubMed ID: 16696755
    [No Abstract]   [Full Text] [Related]  

  • 6. [Application of anti-resorptive drugs for the treatment of osteoporosis].
    Takada J
    Nihon Rinsho; 2006 Feb; 64(2):385-91. PubMed ID: 16454196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bisphosphonates for osteoporosis.
    Drug Ther Bull; 2001 Sep; 39(9):68-72. PubMed ID: 11586803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risedronate for the prevention and treatment of postmenopausal osteoporosis.
    Cranney A; Waldegger L; Zytaruk N; Shea B; Weaver B; Papaioannou A; Robinson V; Wells G; Tugwell P; Adachi JD; Guyatt G
    Cochrane Database Syst Rev; 2003; (4):CD004523. PubMed ID: 14584020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteoporosis: which current treatments reduce fracture risk?
    Baran DT
    Cleve Clin J Med; 2000 Oct; 67(10):701-3. PubMed ID: 11060956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aging bone and osteoporosis: strategies for preventing fractures in the elderly.
    Ettinger MP
    Arch Intern Med; 2003 Oct; 163(18):2237-46. PubMed ID: 14557222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of alendronate and risedronate in preventing and treating osteoporosis.
    Peters ML; Leonard M; Licata AA
    Cleve Clin J Med; 2001 Nov; 68(11):945-51. PubMed ID: 11718433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group.
    Harris ST; Watts NB; Genant HK; McKeever CD; Hangartner T; Keller M; Chesnut CH; Brown J; Eriksen EF; Hoseyni MS; Axelrod DW; Miller PD
    JAMA; 1999 Oct; 282(14):1344-52. PubMed ID: 10527181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Commentary on: Bone mineral density and fracture prevalence in long-term kidney graft recipients.
    Collier J
    Transplantation; 2002 Aug; 74(4):438-9. PubMed ID: 12356012
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of non-vertebral fracture between minodronate and risedronate therapy in elderly female patients with Alzheimer disease.
    Sato Y; Honda Y; Iwamoto J; Amano N
    J Musculoskelet Neuronal Interact; 2013 Sep; 13(3):346-52. PubMed ID: 23989256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastroenterologists and choosing the right bisphosphonate.
    Leder BZ; Kronenberg HM
    Gastroenterology; 2000 Sep; 119(3):866-9. PubMed ID: 10982780
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis.
    Iwamoto J; Takeda T; Sato Y
    Curr Med Res Opin; 2006 May; 22(5):919-28. PubMed ID: 16709313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of highly potent bisphosphonates in the treatment of osteoporosis.
    McClung M
    Curr Osteoporos Rep; 2003 Dec; 1(3):116-22. PubMed ID: 16036074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous zoledronic acid: what are the indications for male osteoporosis?
    Maricic M
    Curr Osteoporos Rep; 2010 Mar; 8(1):4-9. PubMed ID: 20425084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. When do bisphosphonates make the most sense?
    Winzenberg T; Jones G
    J Fam Pract; 2011 Jan; 60(1):18-28. PubMed ID: 21209974
    [No Abstract]   [Full Text] [Related]  

  • 20. Summaries for patients. Drug therapy for osteoporosis.
    Ann Intern Med; 2008 May; 148(9):I28. PubMed ID: 18458273
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.